The Signal

Expert insights and opinions on clinical research and drug development.

Expert insights and opinions on clinical research and drug development.

Category: eCOA

3 Reasons Oncology Studies Should Consider a Pre-Configured eCOA Solution

The FDA’s recent guidance placed an increased emphasis on patient-reported outcome measures (PROMs) for oncology trials. This data provides better insight into the patients’ disease-related symptoms, side effects of treatment, and effect…

EMA Draft Guidance: Here’s What It Tells Us About BYOD

The European Medicines Agency (EMA) draft guidance released this past June on “computerized systems and electronic data in clinical trials” to replace their 2010 reflection paper on…

AAIC Post Event Blog

Here are a few takeaways from Signant’s presentations that you may have missed: Dr. Miller led a product showcase, Glimmers…

Key Technology Elements for Successful Hybrid Trials

As the industry continues to predict and debate what the “new normal” in clinical development will look like in an…

Mixing eCOA Modes: How to Respond Post-COVID Mitigation

Over the early months of the pandemic, we worked with clients to implement mitigations for studies that continued but were…

Five Considerations for BYOD Studies

In our drive to make trial participation simpler, a bring-your-own-device (BYOD) model is thought to be a convenient approach for trial participants to complete patient-reported outcome…

Signant Health Raises the Bar in Ulcerative Colitis Trials with eCOA

The Mayo Clinic Score (MCS) is one of the most commonly used measures of disease activity in clinical trials for…